From Integration to Exclusion
| Autor: | Mariolina Eliantonio, Sabrina Röttger-Wirtz |
|---|---|
| Přispěvatelé: | International and European Law, RS: FdR - CERiM, RS: FdR IC Integratie, RS: FdR Institute MCEL, Public Law, RS: FdR IC Rechtsbescherming, RS: FdR Studio Europa Maastricht, RS: FdR Research Group Globalization & Law Network |
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | European Journal of Risk Regulation, 10(2):PII S1867299X19000321, 393-411. Cambridge University Press |
| ISSN: | 2190-8249 1867-299X |
| DOI: | 10.1017/err.2019.32 |
| Popis: | In the EU, pharmaceuticals are subject to a marketing authorisation requirement that, depending on the type of product concerned, can be obtained either centrally through a Commission decision with EU-wide effects or in the Member States, potentially subject to mutual recognition in composite authorisation procedures. These composite decision-making processes can nowadays be considered a standard way of administrative decision-making in the EU internal market. Yet, judicial supervision remains anchored in the separation of jurisdictions between the national and the EU level, and between national levels. This article explores the challenges posed to judicial review in the case of pharmaceutical marketing authorisations when European administrative composite structures are used. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|